Screener
Cocrystal Pharma COCP Q2 2026 earnings
Reported August 13, 2026 · Before market open
Revenue$105.0KIn line
EPS-$0.23Miss by $0.07
Revenue estimate$105.0K
EPS estimate-$0.17
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$105.0K
EPS estimate-$0.15
Versus estimates
Revenue
Q2 2026$105.0KIn line
Q1 2026$225.0KIn lineDiluted EPS
FAQ
- When did Cocrystal Pharma report Q2 2026 earnings?
- Cocrystal Pharma (COCP) reported Q2 2026 earnings on August 13, 2026 before market open.
- What were Cocrystal Pharma's Q2 2026 revenue and EPS?
- Cocrystal Pharma reported revenue of $105.0K and eps of $-0.23 for Q2 2026.
- Did Cocrystal Pharma beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $105.0K by -. EPS missed the consensus estimate of $-0.17 by $0.07.
- How did Cocrystal Pharma's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 15.0% from $-0.20.
- Where can I find Cocrystal Pharma's Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001493152-26-037573) directly on SEC EDGAR. The filing index links above go to sec.gov.
